Celldex Therapeutics Inc Files For Mixed Shelf; Size Not Disclosed
Portfolio Pulse from Benzinga Newsdesk
Celldex Therapeutics Inc has filed for a mixed shelf offering, according to a SEC filing. The size of the offering has not been disclosed.

November 03, 2023 | 8:09 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Celldex Therapeutics' filing for a mixed shelf offering could potentially dilute existing shares, depending on the size of the offering.
A mixed shelf offering allows a company to issue various types of securities (stocks, bonds, etc.) over a certain period. The size of the offering is not disclosed, but if it's significant, it could dilute existing shares, potentially leading to a decrease in share price.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100